Study finds two cancer drugs could slow Alzheimer's disease in mice, offering promise for reversing symptoms in humans.

Study harnesses a cell-type-specific, multi-target drug discovery strategy grounded in human data and real-world evidence.

Alzheimer’s disease remains one of medicine’s toughest challenges, affecting millions and costing trillions of dollars ...

UCSF researchers find that two FDA-approved cancer drugs significantly improve memory in Alzheimer’s mouse models and reduce ...

Scientists at UCSF and Gladstone Institutes have identified cancer drugs that promise to reverse the changes that occur in ...

With few treatments available to treat Alzheimer’s disease, scientists have turned to cancer drugs as a potential means of ...

Why are generic drugs cheaper? Since generic medicines are essentially copies of branded drugs, they do not have to repeat the rigorous steps that the original drugs had to go through before getting ...

Health Care ProPublica Sued the FDA for Withholding Records About the Safety of Generic Drugs The agency declined to quickly release documents that would identify drugs made at some of the most ...

PURPOSETo evaluate the performance and consistency of large language models (LLMs) across brand and generic oncology drug names in various clinical tasks, addressing concerns about potential ...

The recent dismissal of 13 FDA review staff eliminated precisely the kind of government spending that delivered the most bang for the taxpayers’ buck, writes former FDA Commissioner Scott Gottlieb.

The End of the ‘Generic’ Grocery-Store Brand They’re no longer terrible—in fact, they’re often the draw. By Ellen Cushing ...